
CAS 1428729-56-9
:KIN1148
Description:
KIN1148, identified by its CAS number 1428729-56-9, is a chemical compound that belongs to a class of molecules known for their potential therapeutic applications, particularly in the field of oncology. It is characterized by its specific molecular structure, which includes various functional groups that contribute to its biological activity. KIN1148 acts as a selective inhibitor of certain kinases, which are enzymes that play crucial roles in cell signaling pathways, particularly those involved in cell growth and proliferation. This selectivity is significant as it may lead to reduced side effects compared to non-selective inhibitors. The compound is typically studied for its efficacy in targeting specific cancer types, and its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are critical for determining its suitability for clinical use. As with many investigational drugs, ongoing research is essential to fully understand its mechanism of action, therapeutic potential, and safety profile.
Formula:C19H11N3OS2
Synonyms:- N-Benzo[1,2-d:3,4-d']bisthiazol-2-yl-2-naphthalenecarboxamide
- KIN1148
- N-(Benzo[1,2-d:3,4-d']bis(thiazole)-2-yl)-2-naphthamide
- KIN1148;KIN-1148;KIN 1148
- 2-Naphthalenecarboxamide, N-benzo[1,2-d:3,4-d']bisthiazol-2-yl-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
N-Benzo[1,2-d:3,4-d']bisthiazol-2-yl-2-naphthalenecarboxamide
CAS:Formula:C19H11N3OS2Purity:98%Color and Shape:SolidMolecular weight:361.4401KIN1148
CAS:KIN1148: small-molecule adjuvant, enhances immunity via RIG-I/IRF-3; for FDA-approved avian flu and West Nile virus vaccines.Formula:C19H11N3OS2Purity:97.29%Color and Shape:SolidMolecular weight:361.44N-Benzo[1,2-d:3,4-d']bisthiazol-2-yl-2-naphthalenecarboxamide
CAS:Controlled ProductFormula:C19H11N3OS2Color and Shape:NeatMolecular weight:244.243KIN1148
CAS:<p>KIN1148 is a neutralizing molecule that has been shown to exhibit broad-spectrum antiviral activity against HIV and influenza virus. KIN1148 binds to the hiv envelope protein gp120, thereby inhibiting its interaction with CD4 cells. It also activates the immune system by binding to the HLA-A2 antigen on human dendritic cells. In vitro studies have shown that KIN1148 inhibits the replication of influenza virus in cell culture. This drug also has potential for use as a therapeutic agent in pandemic influenza and avian influenza.</p>Formula:C19H11N3OS2Purity:Min. 95%Molecular weight:361.44 g/mol




